Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer.
Quirino LaiAlessandro VitaleSamuele IesariArmin FinkenstedtGianluca MenniniGabriele SpoletiniMaria Hoppe-LotichiusGiovanni VennarecciTommaso M ManziaDaniele NicoliniAlfonso W AvolioAnna Chiara FrigoIvo GraziadeiMassimo RossiEmmanuel A TsochatzisGerd OttoGiuseppe M EttorreGiuseppe TisoneMarco VivarelliSalvatore AgnesUmberto CilloJan Lerutnull nullPublished in: Hepatology (Baltimore, Md.) (2017)
The ITT transplant survival benefit presented here allows physicians to better select HCC patients waiting for LT. The obtained stratification may lead to an improved and more equitable method of organ allocation. Patients without benefit should be de-listed, whereas patients with large benefit ratio should be prioritized for LT. (Hepatology 2017;66:1910-1919).